133 related articles for article (PubMed ID: 23390656)
1. [Evolution in optimization of stroke treatment].
Zhivolupov SA; Samartsev IN; Ivanova KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8 Pt 2):49-58. PubMed ID: 23390656
[TBL] [Abstract][Full Text] [Related]
2. [Contemporary paradigm of rational stroke treatment].
Zhivolupov SA; Butakova YS; Samartsev IN
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8 Pt 2):82-87. PubMed ID: 28635766
[TBL] [Abstract][Full Text] [Related]
3. [Theoretical and practical aspects of treatment and prevention of acute cerebral blood cerculation disorders].
Zhivolupov SA; Samartsev IN; Bodrova TV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3 Pt 2):37-42. PubMed ID: 24781240
[TBL] [Abstract][Full Text] [Related]
4. [Mexidol in the complex treatment of patients in the acute period of tick borne encephalitis].
Udintseva IN; Bartfel't NN; Zhukova NG; Poponina AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):34-8. PubMed ID: 23096037
[TBL] [Abstract][Full Text] [Related]
5. [Correction of free-radical oxidation as a pathogenetic approach to the treatment of acute ischemic stroke].
Chugunov AV; Kamchatnov PR; Mikhaĭlova NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10 Suppl 2):65-8. PubMed ID: 20229636
[TBL] [Abstract][Full Text] [Related]
6. [An analysis of mexidol efficacy in the complex treatment of patients with ischemic stroke].
Lutskiĭ MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):57-9. PubMed ID: 20740717
[No Abstract] [Full Text] [Related]
7. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ; Zaharov YA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
[TBL] [Abstract][Full Text] [Related]
8. [Adaptogenic effects of mexidol in chronic cerebral ischemia].
Antipenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):44-9. PubMed ID: 22677755
[TBL] [Abstract][Full Text] [Related]
9. [Modern strategies of protection of hypoxic-ischemic brain damage].
Yanishevsky SN; Tsygan NV; Golokhvastov SY; Andreev RV; Litvinenko IV; Karpova OS; Yakovleva VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12. Vyp. 2):78-86. PubMed ID: 29411750
[TBL] [Abstract][Full Text] [Related]
10. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
[TBL] [Abstract][Full Text] [Related]
11. SAINT-I worked, but the neuroprotectant is not NXY-059.
Proctor PH; Tamborello LP
Stroke; 2007 Oct; 38(10):e109; author reply e110. PubMed ID: 17717310
[No Abstract] [Full Text] [Related]
12. An update of neuroprotectants in clinical development for acute stroke.
Lutsep H; Clark W
Curr Opin Investig Drugs; 2001 Dec; 2(12):1732-6. PubMed ID: 11892936
[TBL] [Abstract][Full Text] [Related]
13. [Neurometabolic therapy in secondary prevention of stroke].
Koval'chuk VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3):24-8. PubMed ID: 24781222
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke].
Chefranova ZhIu; Makotrova TA; Udachin VA; Koledintseva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):49-52. PubMed ID: 22810741
[TBL] [Abstract][Full Text] [Related]
15. Targets of cytoprotection in acute ischemic stroke: present and future.
Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
[TBL] [Abstract][Full Text] [Related]
16. Future of neuroprotective drugs in doubt.
Birmingham K
Nat Med; 2002 Jan; 8(1):5. PubMed ID: 11786882
[No Abstract] [Full Text] [Related]
17. [Development of new stroke therapies: outlook for neuroprotective drugs].
Rogalewski A; Schäbitz WR
Nervenarzt; 2008 Feb; 79(2):218-24. PubMed ID: 18214414
[TBL] [Abstract][Full Text] [Related]
18. [Combined administration of mexidol with known medicines].
Voronina TA; Ivanova EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4):115-124. PubMed ID: 31156232
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities of the application of antioxidants and antihypoxants in a complex therapy of obsessive conditions in different mental disorders].
Podsevatkin VG; Kiriukhina SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):56-61. PubMed ID: 20517227
[TBL] [Abstract][Full Text] [Related]
20. Is it time to definitely abandon neuroprotection in acute ischemic stroke?
Sacchetti ML
Stroke; 2008 Jun; 39(6):1659-60. PubMed ID: 18369169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
